Evidence map›Paper›PMID 40369592›Full record

ArticleBMC veterinary research2025

Genetic characterization and pathogenicity of two recombinant PRRSV-2 strains from lineages 1, 3, 5, and 8 emerged in China.

Chunhua Wei, Chen Liu, Guangsong Chen, Yuan Yang, Jiarui Li, Huijuan Dan, Ailing Dai, Cuiqin Huang, Manlin Luo, Jiankui Liu

Erratum issuedAbstract read
In one paragraph

Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Chunhua WeiCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Chen LiuCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Guangsong ChenCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Yuan YangCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Jiarui LiCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Huijuan DanCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Ailing DaiCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Cuiqin HuangCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China.
Manlin LuoCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, 510642, China.
Jiankui LiuCollege of Life Sciences, Longyan University, Longyan, Fujian, 364012, China. liujiankui99@126.com.

Funding

Leading Project Foundation of Science Department of Fujian Province 2021N0032)
6 · The paper itself

Abstract

backgroundPorcine reproductive and respiratory syndrome virus (PRRSV) is a major economic threat to the global swine industry. Currently, NADC30-like PRRSV has undergone complex recombination with local Chinese strains, which has exacerbated the evolution of PRRSV. Recently, new recombinant PRRSV-2 strains from four lineages (lineages 1, 3, 5, and 8) have emerged in China. However, information on the pathogenicity of the novel isolate in China remains limited. To further our knowledge about the isolate, FJLIUY2017 and PRRSV2/CN/G8/2018 were selected to analyze their pathogenicity for piglets.

methodsThe PRRSV FJLIUY2017 and PRRSV2/CN/G8/2018 strains were isolated by porcine alveolar macrophages (PAMs) and MARC-145CD

resultsFull-length genome analysis revealed that FJLIUY2017 and PRRSV2/CN/G8/2018 share 89.2% identity with each other, and in particular, they had a low degree of homology (< 92%) with PRRSV sequences available in GenBank. Phylogenetic and recombination analyses revealed that the two strains were recombinant viruses from lineages 1, 3, 5.1, and 8.7 strains. Animal studies indicated that FJLIUY-2017 resulted in the typical clinical signs of PRRSV, including persistent fever, higher viremia, severe lung lesions, and 20% mortality, whereas PRRSV2/CN/G8/2018 caused moderate clinical symptoms and no mortality during the challenge period. Hyper-immune sera against the major vaccine strains JXA1-R (lineage 8) and Ingelvac PRRS MLV (Lineage 5) failed to neutralize two strains.

conclusionsFJLIUY-2017 caused persistent fever, higher viremia, 20% mortality and exhibited higher pathogenicity in piglets compared to PRRSV2/CN/G8/2018. Our results suggest that recombination between different PRRSV-2 lineages can result in the development of PRRSV variants with increased pathogenicity.

Indexed as

Porcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusAnimalsAntibodies, ViralChinaGenome, ViralPhylogenyRecombination, GeneticSwineVirulenceAntibodies, ViralGenetic characterizationPathogenicityPorcine reproductive and respiratory syndrome virus (PRRSV)Recombination

Identifiers

PMID40369592
PMCPMC12079828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.